Dr. Thatcher R. Heumann
Claim this profileVanderbilt University/Ingram Cancer Center
Area of expertise
Liver Cancer
Thatcher R. Heumann has run 3 trials for Liver Cancer. Some of their research focus areas include:
Cancer
Thatcher R. Heumann has run 3 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Vanderbilt University/Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Clinical Trials Thatcher R. Heumann is currently running
Tinengotinib
for Bile Duct Cancer
This trial is testing an oral medication called Tinengotinib for patients with a specific type of bile duct cancer that has not responded to other treatments. The medication works by blocking a protein that helps cancer cells grow. The goal is to see if Tinengotinib can slow down or stop the cancer in these patients.
Recruiting
2 awards
Phase 3
Durvalumab + Chemotherapy
for Bile Duct Cancer
This phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) that can be removed by surgery (resectable). Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as gemcitabine and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving durvalumab with gemcitabine and cisplatin before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed in patients with high risk resectable cholangiocarcinoma.
Recruiting
1 award
Phase 2
More about Thatcher R. Heumann
Clinical Trial Related
4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Thatcher R. Heumann has experience with
- Cisplatin
- Nivolumab
- Ipilimumab
- Tinengotinib
- Physician's Choice
- BAY 1895344
Breakdown of trials Thatcher R. Heumann has run
Liver Cancer
Cancer
Bile Duct Cancer
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thatcher R. Heumann specialize in?
Thatcher R. Heumann focuses on Liver Cancer and Cancer. In particular, much of their work with Liver Cancer has involved Stage IV patients, or patients who are Stage III.
Is Thatcher R. Heumann currently recruiting for clinical trials?
Yes, Thatcher R. Heumann is currently recruiting for 3 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Thatcher R. Heumann has studied deeply?
Yes, Thatcher R. Heumann has studied treatments such as Cisplatin, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Thatcher R. Heumann?
Apply for one of the trials that Thatcher R. Heumann is conducting.
What is the office address of Thatcher R. Heumann?
The office of Thatcher R. Heumann is located at: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee 37232 United States. This is the address for their practice at the Vanderbilt University/Ingram Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.